Used in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly those targeting central nervous system disorders. Its structure supports the development of novel therapeutics with potential applications in treating neurological and psychiatric conditions. The compound's fluorinated aryl group enhances binding affinity and metabolic stability, making it valuable in drug design. It is also explored in medicinal chemistry for optimizing pharmacokinetic properties of candidate drugs.